SCHEMBL1561215

SCHEMBL1561215

CN1CCN(C(=O)N(C)C2CCCCC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
HTR1A P08908 1/20 0.46
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LIPE Q05469 1/20 0.41
HSD11B1 P28845 2/20 0.41
HSD11B2 P80365 1/20 0.41
CYP1A2 P05177 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
VNN1 O95497 1/20 0.40
CHRM3 P20309 1/20 0.40
PKM P14618 1/20 0.40
FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18389969 0.91 HTR1A (0.50) LMNAHTR1AALDH1A1KDM4EHTT
SCHEMBL25568891 0.89 HTR1A (0.48) LMNAHTR1AALDH1A1HTTHSD11B1
SCHEMBL24518383 0.87 LIPE (0.44) ALDH1A1HTTTSHRHPGDLIPE
SCHEMBL15551380 0.87 LIPE (0.44) ALDH1A1HTTTSHRHPGDLIPE
SCHEMBL28019652 0.87 LIPE (0.44) ALDH1A1HTTTSHRHPGDLIPE
SCHEMBL19012442 0.83 MAPT (0.45) HTR1AALDH1A1HTTHSD11B1CYP1A2
SCHEMBL1561145 0.83 HTR1A (0.43) LMNAHTR1AALDH1A1HTTHSD11B1
SCHEMBL19001142 0.81 LIPE (0.39) ALDH1A1TSHRHPGDRAB9ALIPE
SCHEMBL31097151 0.81 HPGD (0.43) ALDH1A1HTTHPGDSMN1; SMN2LIPE
SCHEMBL30967383 0.81 CA2 (0.44) ALDH1A1TSHRHPGDLIPEHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091925-B1 BICYCLIC HETEROCYCLES, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION OF SAME BOEHRINGER INGELHEIM INT (DE) 2011-04-06 EP claimed
EP-2373329-A2 USE OF EPIDERMAL GROWTH FACTOR INHIBITORS IN THE TREATMENT OF VIRAL INFECTION The Regents of the University of California (US) 2011-10-12 EP disclosed